Neuroleptic drug use for people with dementia in care homes

Journal of Dementia Care

Volumn 13, Issue 4, 2005, Pages 28-30

  Jackson, Graham ^a  

^a Leverndale Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; CARBAMAZEPINE; CHLORPROMAZINE; CITALOPRAM; DIAZEPAM; DONEPEZIL; GALANTAMINE; HALOPERIDOL; LORAZEPAM; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; RIVASTIGMINE; SULPIRIDE; THIORIDAZINE; TRAZODONE; VALPROIC ACID;

ALZHEIMER DISEASE; ARTICLE; BEHAVIOR DISORDER; COGNITIVE DEFECT; DELUSION; DEMENTIA; DISEASE EXACERBATION; DISTRESS SYNDROME; DRUG FATALITY; FOOD AND DRUG ADMINISTRATION; HALLUCINATION; HEALTH CARE QUALITY; HOME CARE; HUMAN; LEWY BODY; PRACTICE GUIDELINE; PRESCRIPTION; PSYCHOSIS; SCHIZOPHRENIA; UNITED KINGDOM; UNITED STATES; VOMITING;

EID: 22544444520     PISSN: 13518372     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. AD Collaborative Group (2004) Long term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double blind trial. Lancet 363 2105-2115
2. Ballard C, Margallo-Lana M, Juszczak E, Douglas S, Swann A, Thomas AA, O'Brien J, Everratt A, Sadler S, Maddison C, Lee L, Bannister C, Elvish R, Jacoby R (2005) Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial. British Medical Journal 330 874.
3. Committee on Safety of Medicines (2004) Atypical antipsychotic drugs and stroke. www.mca.gov.uk
4. Downs M, Jackson GA, Crossan B, Cook A, Pratt R, Turner S (1999) The prevalence and management of challenging behaviour in nursing homes. Dementia Services Development Centre, Stirling.
5. Jackson GA, Templeton GJ, Whyte J (1999). An overview of behaviour difficulties found in long term care settings. International Journal of Geriatric Psychiatry 14 426-430
6. Lee PE, Gill SS, Freedman M, Bronskill SE, Hillmer MP, Rochon PA (2004) Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: systematic review. British Medical Journal 329 75-78
7. McGrath AM & Jackson GA (1996) A survey of neuroleptic drug use in nursing homes in Glasgow. British Medical Journal 312 611-612.
8. McShane R, Keene J, Gedling K, Fairburn C, Jacoby R, Hope T (1997) Do neuroleptic drugs hasten cognitive decline in dementia? Prospective study with necropsy follow up. British Medical Journal 314 266-270.
9. National Institute for Clinical Excellence (2005) Appraisal consultation document: Alzheimer's disease - donepezil, rivastigmine, galantamine and memantine (review). Accessed at www.nice.org.uk
10. Oborne CA, Hooper R, Li KC, Swift CG, Jackson SHD (2002). An indicator of appropriate neuroleptic prescribing in nursing homes. Age and Ageing 31 435-439.
11. Scottish Intercollegiate Guidelines Network (1999) Interventions in the management of behavioural and psychological aspects of dementia. SIGN, Edinburgh.
12. Spore DL, Mor V, Larrat P, Hawes C, Hiris J (1997) Inappropriate prescriptions for elderly residents of board and care facilities. American Journal of Public Health 87(3) 404-409.